Journal of Hematology & Oncology (Sep 2020)
A single-cell survey of cellular hierarchy in acute myeloid leukemia
- Junqing Wu,
- Yanyu Xiao,
- Jie Sun,
- Huiyu Sun,
- Haide Chen,
- Yuanyuan Zhu,
- Huarui Fu,
- Chengxuan Yu,
- Weigao E.,
- Shujing Lai,
- Lifeng Ma,
- Jiaqi Li,
- Lijiang Fei,
- Mengmeng Jiang,
- Jingjing Wang,
- Fang Ye,
- Renying Wang,
- Ziming Zhou,
- Guodong Zhang,
- Tingyue Zhang,
- Qiong Ding,
- Zou Wang,
- Sheng Hao,
- Lizhen Liu,
- Weiyan Zheng,
- Jingsong He,
- Weijia Huang,
- Yungui Wang,
- Jin Xie,
- Tiefeng Li,
- Tao Cheng,
- Xiaoping Han,
- He Huang,
- Guoji Guo
Affiliations
- Junqing Wu
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Yanyu Xiao
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Jie Sun
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine
- Huiyu Sun
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Haide Chen
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Yuanyuan Zhu
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine
- Huarui Fu
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine
- Chengxuan Yu
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Weigao E.
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Shujing Lai
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Lifeng Ma
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Jiaqi Li
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Lijiang Fei
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Mengmeng Jiang
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Jingjing Wang
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Fang Ye
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Renying Wang
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Ziming Zhou
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Guodong Zhang
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Tingyue Zhang
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- Qiong Ding
- Wuhan Biobank Co., LTD
- Zou Wang
- Wuhan Biobank Co., LTD
- Sheng Hao
- Wuhan Biobank Co., LTD
- Lizhen Liu
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine
- Weiyan Zheng
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine
- Jingsong He
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine
- Weijia Huang
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine
- Yungui Wang
- Institute of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine
- Jin Xie
- State Key Laboratory of Fluid Power and Mechatronic Systems, Zhejiang University
- Tiefeng Li
- Institute of Applied Mechanics, Zhejiang University
- Tao Cheng
- Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
- Xiaoping Han
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- He Huang
- Institute of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine
- Guoji Guo
- Center for Stem Cell and Regenerative Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine
- DOI
- https://doi.org/10.1186/s13045-020-00941-y
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 19
Abstract
Abstract Background Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy and has a prognosis that varies with its genetic complexity. However, there has been no appropriate integrative analysis on the hierarchy of different AML subtypes. Methods Using Microwell-seq, a high-throughput single-cell mRNA sequencing platform, we analyzed the cellular hierarchy of bone marrow samples from 40 patients and 3 healthy donors. We also used single-cell single-molecule real-time (SMRT) sequencing to investigate the clonal heterogeneity of AML cells. Results From the integrative analysis of 191727 AML cells, we established a single-cell AML landscape and identified an AML progenitor cell cluster with novel AML markers. Patients with ribosomal protein high progenitor cells had a low remission rate. We deduced two types of AML with diverse clinical outcomes. We traced mitochondrial mutations in the AML landscape by combining Microwell-seq with SMRT sequencing. We propose the existence of a phenotypic “cancer attractor” that might help to define a common phenotype for AML progenitor cells. Finally, we explored the potential drug targets by making comparisons between the AML landscape and the Human Cell Landscape. Conclusions We identified a key AML progenitor cell cluster. A high ribosomal protein gene level indicates the poor prognosis. We deduced two types of AML and explored the potential drug targets. Our results suggest the existence of a cancer attractor.
Keywords
- Acute myeloid leukemia
- Single-cell mRNA sequencing
- Microwell-seq
- Ribosomal protein
- Single-molecule real-time sequencing
- Cancer attractor